Sangamo Therapeutics
SGMO
#10505
Rank
S$26.86 M
Marketcap
S$0.06484
Share price
-28.57%
Change (1 day)
-90.04%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$32.87 Million. In 2024 the company made an earning of -S$0.13 Billion, an increase over its 2023 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion12.54%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.27 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$0.11 Billion36.89%
2017 -S$73.1 Million-22.32%
2016 -S$94.11 Million54.86%
2015 -S$60.77 Million75.62%
2014 -S$34.61 Million0.13%
2013 -S$34.56 Million
2011 -S$46.46 Million43.66%
2010 -S$32.34 Million28.52%
2009 -S$25.17 Million-23.55%
2008 -S$32.92 Million2.45%
2007 -S$32.13 Million19.5%
2006 -S$26.89 Million50.78%
2005 -S$17.83 Million75%
2004 -S$10.19 Million-33.25%
2003 -S$15.27 Million-62.27%
2002 -S$40.46 Million102.82%
2001 -S$19.95 Million23.21%
2000 -S$16.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.69 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.78 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.10 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$3.28 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.70 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$17.05 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.12 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.50 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA